First Time Loading...

INVO Bioscience Inc
NASDAQ:INVO

Watchlist Manager
INVO Bioscience Inc Logo
INVO Bioscience Inc
NASDAQ:INVO
Watchlist
Price: 0.98 USD -0.01% Market Closed
Updated: Apr 29, 2024

INVO Bioscience Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

INVO Bioscience Inc
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
INVO Bioscience Inc
NASDAQ:INVO
Operating Income
-$6.8m
CAGR 3-Years
-7%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.1B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.4B
CAGR 3-Years
39%
CAGR 5-Years
7%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Operating Income
$4.4B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.6B
CAGR 3-Years
-1%
CAGR 5-Years
11%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$1.9B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
11%

See Also

What is INVO Bioscience Inc's Operating Income?
Operating Income
-6.8m USD

Based on the financial report for Dec 31, 2023, INVO Bioscience Inc's Operating Income amounts to -6.8m USD.

What is INVO Bioscience Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-21%

Over the last year, the Operating Income growth was 36%. The average annual Operating Income growth rates for INVO Bioscience Inc have been -7% over the past three years , -21% over the past five years .